Osmotica Pharmaceuticals focuses on developing innovative drug delivery technologies that enhance the therapeutic efficacy and patient experience of their pharmaceutical products. The company employs a range of proprietary technologies, including osmotic drug delivery systems, which allow for controlled and sustained release of medications. This technology is designed to improve the bioavailability of drugs, ensuring that they are released at a consistent rate over time, thereby optimizing their effectiveness and minimizing side effects.

In addition to osmotic systems, Osmotica also utilizes advanced formulation techniques to create products that can address specific patient needs, such as extended-release formulations and combination therapies. Their commitment to scientific research and development enables them to explore new therapeutic areas and improve existing treatments, ultimately aiming to provide better health outcomes for patients. Through these innovative technologies, Osmotica Pharmaceuticals strives to enhance the overall quality of life for individuals requiring medication.

Hungary

Osmotica Pharmaceutical is a fully-integrated pharmaceutical company with demonstrated expertise in developing commercially successful products. As one of the world's leading osmotic drug delivery companies, we leverage our significant resources in R&D and proprietary drug delivery technology to address the growing need of the global patient population.

We have the resources and experience to successfully commercialize our products through our subsidiaries, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC.

Osmotica Pharmaceuticals

Company Details